Panavance Therapeutics
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1055 Westlakes Dr Ste 300, Berwyn, Penns...Website
www.panavance.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Panavance Therapeutics
Persevere Therapeutics, formerly known as Panavance, focuses on innovative therapeutic solutions. The company is dedicated to advancing its scientific pipeline, particularly in the area of Misetionamide and its mechanism of action. Persevere Therapeutics aims to serve clients in the healthcare sector, particularly those seeking novel treatments. Their mission is encapsulated in the motto 'Never Give Up,' reflecting their commitment to perseverance in therapeutic development.Explore more
Panavance Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Panavance Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Panavance Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Panavance Therapeutics recently announced quarterly report
Click to see if Panavance Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Panavance Therapeutics launches new products
Panavance Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Panavance Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Panavance Therapeutics
Funding: Get notified immidiatlly once Panavance Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Panavance Therapeutics
Compare insights from companies similar to Panavance Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Panavance Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Panavance Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Panavance Therapeutics.
Panavance Therapeutics Tech Stack
A closer look at the technologies used by Panavance Therapeutics
See more technologies
Panavance Therapeutics News & Media
Panavance Announces New Discovery that Misetionamide Directly Inhibits Oncogenic Transcription Factor c-MYC
New finding builds upon previous confirmation of misetionamide’s direct inhibition of NFkBPanavance Therapeutics Provides Update on Phase 1 Clinical Trial of Misetionamide in Pancreatic Cancer at 2024 Visceral Medicine Congress
Misetionamide-gemcitabine combination demonstrates very good safety profile and potential therapeutic benefit in the challenging treatment of pancreatic adenocarcinomaPanavance Therapeutics Announces Foundational Publication of Misetionamide (GP-2250) in Ovarian Cancer in the Journal, Cancer Medicine
Misetionamide demonstrated significant single agent activity and synergy with either PARP inhibitors (PARPi) or bevacizumab in ovarian cancer preclinical studies Profound effects on tumor metabolism, anti-angiogenic activity, protein synthesis, and DNA transcriptionAnti-Cancer Drugs Publishes Preclinical Data Demonstrating the Broad Antineoplastic Activity of Panavance’s Misetionamide (GP-2250)
Misetionamide showed broad antineoplastic activity in 15 different cancer types including multiple human cancer cell lines with no detrimental effect on normal cells
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Panavance Therapeutics
Sign Up For FreeTo access detailed company insights
Persevere Therapeutics, formerly known as Panavance, focuses on innovative therapeutic solutions. The company is dedicated to advancing its scientific pipeline, particularly in the area of Misetionamide and its mechanism of action. Persevere Therapeutics aims to serve clients in the healthcare sector, particularly those seeking novel treatments. Th... Read More
